Get the Stockscreener App
281.77
0.89%
-2.54
After Hours:
281.77
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $281.77, with a volume of 788.45K.
It is down -0.89% in the last 24 hours and down -1.80% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$284.31
Open:
$284.5
24h Volume:
788.45K
Relative Volume:
1.15
Market Cap:
$20.27B
Revenue:
$2.96B
Net Income/Loss:
$487.70M
P/E Ratio:
42.21
EPS:
6.6758
Net Cash Flow:
$344.00M
1W Performance:
+1.67%
1M Performance:
-1.80%
6M Performance:
+33.27%
1Y Performance:
-12.24%
1-Day Range:
$276.04
$285.54
1-Week Range:
$269.08
$285.54
52-Week Range:
$187.43
$348.90
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
281.77 | 20.45B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
568.65 | 201.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.76 | 55.25B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.99 | 39.31B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.51 | 36.70B | 5.26B | 1.44B | 1.76B | 9.7713 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
What makes West Pharmaceutical Services Inc. stock appealing to growth investorsJuly 2025 Pullbacks & Pattern Based Trade Signal System - Newser
West Pharmaceutical Services (WST) Rebounded in Q3 - Finviz
Why global investors buy West Pharmaceutical Services Inc. (WPS) stockWeekly Investment Report & Verified Swing Trading Watchlist - Newser
3 Reasons WST is Risky and 1 Stock to Buy Instead - Finviz
Why millennials buy West Pharmaceutical Services Inc. (WPS) stockPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - Newser
Pharmaceutical Cartridges Industry Forecast Reveals - openPR.com
Will West Pharmaceutical Services Inc. stock keep raising dividendsProduct Launch & Free Reliable Trade Execution Plans - Newser
Will West Pharmaceutical Services Inc. stock profit from AI boomJuly 2025 Short Interest & Weekly Return Optimization Alerts - Newser
Morgan Stanley Initiates West Pharmaceutical Services at Equalweight With $285 Price Target - MarketScreener
How West Pharmaceutical Services Inc. (WPS) stock reacts to new regulationsWeekly Profit Summary & Real-Time Buy Signal Alerts - Newser
Published on: 2025-12-02 02:46:24 - Newser
How strong dollar benefits West Pharmaceutical Services Inc. stockJuly 2025 Review & High Conviction Investment Ideas - Newser
West Pharmaceutical Services (WST): Evaluating Valuation After Recent Momentum Shift - Sahm
West Pharmaceutical Services earns excellence award for syringe innovation - Traders Union
West Pharmaceutical: Back To Growth (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services Wins Product Launch Award for Its West Synchrony S1 Prefillable Syringe System - Pharmaceutical Technology
WST Investors Have Opportunity to Lead West Pharmaceutical Servic - The National Law Review
Will West Pharmaceutical Services Whiff on Revenues Next Quarter? - AOL.com
Cell Therapy Packaging Market Trends and Companies Data 2025-35 - GlobeNewswire Inc.
West Pharmaceutical Services, I (WST) Stock forecasts - Yahoo Finance UK
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo! Finance Canada
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Sustainable Pharmaceutical Packaging Market | Global Market Analysis Report2035 - Fact.MR
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
A Look at West Pharmaceutical Services (WST) Valuation Following Robust Q3 Earnings and Upgraded Guidance - Sahm
West Pharmaceutical Raises 2025 Outlook After Strong Third-Quarter Growth - MSN
West Pharmaceutical Services Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com
West Pharmaceutical Services (WST): Gauging Valuation After Q3 Beat, Raised Guidance, and Bullish Market Momentum - Yahoo Finance
What Catalysts Could Shift the Narrative for West Pharma After Analyst Upgrades and New Guidance - Yahoo Finance
How Strong Q3 Results and Raised Guidance At West Pharmaceutical Services (WST) Have Changed Its Investment Story - Sahm
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know - The Globe and Mail
When Should You Buy West Pharmaceutical Services, Inc. (NYSE:WST)? - 富途牛牛
How West Pharmaceutical Services Inc. stock responds to bond marketWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
What Are Wall Street Analysts' Target Price for West Pharmaceutical Services Stock? - Yahoo Finance
West Pharmaceutical at Stephens Conference: Optimism Amid Strategic Growth By Investing.com - Investing.com Canada
Looking Into West Pharmaceutical Services Inc's Recent Short Interest - Benzinga
Jefferies Remains a Buy on West Pharmaceutical Services (WST) - The Globe and Mail
How West Pharmaceutical Services Inc. stock reacts to fiscal policies2025 Trade Ideas & Fast Gain Swing Alerts - newser.com
Why millennials buy West Pharmaceutical Services Inc. stockWeekly Investment Summary & Technical Pattern Based Signals - newser.com
How West Pharmaceutical Services Inc. stock behaves in tightening cyclesVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
How geopolitical risks impact West Pharmaceutical Services Inc. stock2025 EndofYear Setup & Trade Opportunity Analysis Reports - newser.com
Real time alert setup for West Pharmaceutical Services Inc. performance - newser.com
Will West Pharmaceutical Services Inc. stock deliver strong dividend growthTrade Performance Summary & Weekly High Potential Alerts - newser.com
Will West Pharmaceutical Services Inc. stock maintain growth story2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
How West Pharmaceutical Services Inc. stock valuation compares with sectorWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com
Transcript : West Pharmaceutical Services, Inc. Presents at Stephens Annual Investment Conference 2025, Nov-20-2025 11 - MarketScreener
Will West Pharmaceutical Services Inc. stock beat EPS estimatesGold Moves & Smart Swing Trading Techniques - newser.com
How West Pharmaceutical Services Inc. (WPS) stock behaves in tightening cyclesJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
How West Pharmaceutical Services Inc. (WPS) stock trades pre earningsCEO Change & Technical Confirmation Alerts - newser.com
What is the fair value estimate for West Pharmaceutical Services Inc. stock in 2025July 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
West Pharmaceutical Services Inc Stock (WST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Reiss-Clark Cindy | Chief Commercial Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
5,131 |
| MacKay Kimberly Banks | SVP, GC & Corporate Secretary |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
1,605 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
6,823 |
| Winters Chad | VP, Chief Accounting Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
82 |
17,313 |
1,391 |
| Witherspoon Charles | VP & Treasurer |
Feb 18 '25 |
Option Exercise |
211.00 |
66 |
13,864 |
1,319 |
| Green Eric Mark | President, CEO and Board Chair |
Feb 18 '25 |
Option Exercise |
211.00 |
2,461 |
519,269 |
170,369 |
0.21%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):